In re BioData Medical Laboratories, Inc., 6:16-ap-01299-MW. (2018)
Court: United States Bankruptcy Court, C.D. California
Number: inbco20181211649
Visitors: 6
Filed: Dec. 10, 2018
Latest Update: Dec. 10, 2018
Summary: Order on Seventh Stipulation to Continue Pretrial Conference MARK S. WALLACE , Bankruptcy Judge . The Court, having considered that certain Seventh Stipulation to Continue Pretrial Conference " (the " Stipulation ") entered into by and between Merchant Cash & Capital, LLC, the defendant in the above-captioned adversary proceeding (the " Adversary Proceeding "), on the one hand, and Todd A. Frealy, Chapter 7 Trustee for the bankruptcy estate of BioData Medical Laboratories, Inc., the Chapte
Summary: Order on Seventh Stipulation to Continue Pretrial Conference MARK S. WALLACE , Bankruptcy Judge . The Court, having considered that certain Seventh Stipulation to Continue Pretrial Conference " (the " Stipulation ") entered into by and between Merchant Cash & Capital, LLC, the defendant in the above-captioned adversary proceeding (the " Adversary Proceeding "), on the one hand, and Todd A. Frealy, Chapter 7 Trustee for the bankruptcy estate of BioData Medical Laboratories, Inc., the Chapter..
More
Order on Seventh Stipulation to Continue Pretrial Conference
MARK S. WALLACE, Bankruptcy Judge.
The Court, having considered that certain Seventh Stipulation to Continue Pretrial Conference" (the "Stipulation") entered into by and between Merchant Cash & Capital, LLC, the defendant in the above-captioned adversary proceeding (the "Adversary Proceeding"), on the one hand, and Todd A. Frealy, Chapter 7 Trustee for the bankruptcy estate of BioData Medical Laboratories, Inc., the Chapter 7 debtor and the original plaintiff in the above-captioned adversary proceeding, on the other hand, and good cause appearing therefor,
IT IS HEREBY ORDERED as follows:
1. The Stipulation is approved.
2. The pretrial conference in the Adversary Proceeding shall be continued from December 6, 2018 at 9:00 a.m. to February 28, 2019 at 9:00 a.m.
FootNotes
1. Todd A. Frealy, the duly appointed chapter 7 trustee, was substituted automatically as plaintiff in place of BioData Medical Laboratories, Inc. upon his appointment as chapter 11 trustee on or about June 26, 2017 in accordance with Federal Rule of Bankruptcy Procedure 2012(a).
Source: Leagle
